ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Retinitis Pigmentosa (Retinitis) Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-18J5979
Home | Market Reports | People & Society
Global Retinitis Pigmentosa Retinitis Market Insights Forecast to 2028
BUY CHAPTERS

Global Retinitis Pigmentosa (Retinitis) Market Insights, Forecast to 2030

Code: QYRE-Auto-18J5979
Report
December 2024
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Amgen Inc
Amarantus Bioscience Holdings
Acucela Inc
Applied Genetic Technologies Corp
Asklepios BioPharmaceutical
Astellas Pharma
Caladrius Biosciences
Dompe Farmaceutici SpA
Dormant Projects
GenSight Biologics SA
Grupo Ferrer Internacional SA
ID Pharma
InFlectis BioScience
Ionis Pharmaceuticals
Mimetogen Pharmaceuticals
M's Science Corp
Nanovector s.r.l.
Novartis
Novelion Therapeutics
ProQR Therapeutics
ReNeuron Group Plc
SanBio
Shire (Takeda Pharmaceutical)
Spark Therapeutics
Sun Pharma Advanced Research Company

Retinitis Pigmentosa (Retinitis) Market

Retinitis pigmentosa is a kind of cortex on retinal pigment degeneration, chronic, progressive visual function, genetic, nutrition is not virtuous, retinal degenerative eye disease, the disease involving the eyes, men more than women, more incidence of 10 to 20 years old, a few people with the disease in the home, the faster progress in the earlier onset, curative effect is poorer, old age comes on slowly.
Market Analysis and Insights: Global Retinitis Pigmentosa (Retinitis) Market
The global Retinitis Pigmentosa (Retinitis) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Retinitis Pigmentosa (Retinitis) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Retinitis Pigmentosa (Retinitis) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Retinitis Pigmentosa (Retinitis) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Retinitis Pigmentosa (Retinitis) include Sanofi, Amgen, Amarantus Bioscience Holdings, Acucela, Applied Genetic Technologies Corp, Asklepios BioPharmaceutical, Astellas Pharma, Caladrius Biosciences and Dompe Farmaceutici SpA, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Retinitis Pigmentosa (Retinitis) is widely used in various fields, such as Hospitals, Eye Clinics and Other,, etc. Hospitals provides greatest supports to the Retinitis Pigmentosa (Retinitis) industry development. In 2023, global % revenue of Retinitis Pigmentosa (Retinitis) went into Hospitals filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Retinitis Pigmentosa (Retinitis) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Retinitis Pigmentosa (Retinitis), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Retinitis Pigmentosa (Retinitis), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Retinitis Pigmentosa (Retinitis) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Retinitis Pigmentosa (Retinitis) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Retinitis Pigmentosa (Retinitis) revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Retinitis Pigmentosa (Retinitis) Market Report

Report Metric Details
Report Name Retinitis Pigmentosa (Retinitis) Market
Segment by Type
  • General Treatment
  • Traditional Chinese Medicine
  • Gene Therapy
  • The Surgical Treatment
  • Other
Segment by Application
  • Hospitals
  • Eye Clinics
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, Amgen, Amarantus Bioscience Holdings, Acucela, Applied Genetic Technologies Corp, Asklepios BioPharmaceutical, Astellas Pharma, Caladrius Biosciences, Dompe Farmaceutici SpA, Dormant Projects, GenSight Biologics SA, Grupo Ferrer Internacional SA, ID Pharma, InFlectis BioScience, Ionis Pharmaceuticals, Mimetogen Pharmaceuticals, M's Science Corp, Nanovector srl, Novartis AG, Novelion Therapeutics, ProQR Therapeutics, ReNeuron Group Plc, SanBio, Shire (Takeda Pharmaceutical), Spark Therapeutics, Sun Pharma Advanced Research Company
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Retinitis Pigmentosa (Retinitis) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Retinitis Pigmentosa (Retinitis) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Retinitis Pigmentosa (Retinitis) revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Retinitis Pigmentosa (Retinitis) Market report?

Ans: The main players in the Retinitis Pigmentosa (Retinitis) Market are Sanofi, Amgen, Amarantus Bioscience Holdings, Acucela, Applied Genetic Technologies Corp, Asklepios BioPharmaceutical, Astellas Pharma, Caladrius Biosciences, Dompe Farmaceutici SpA, Dormant Projects, GenSight Biologics SA, Grupo Ferrer Internacional SA, ID Pharma, InFlectis BioScience, Ionis Pharmaceuticals, Mimetogen Pharmaceuticals, M's Science Corp, Nanovector srl, Novartis AG, Novelion Therapeutics, ProQR Therapeutics, ReNeuron Group Plc, SanBio, Shire (Takeda Pharmaceutical), Spark Therapeutics, Sun Pharma Advanced Research Company

What are the Application segmentation covered in the Retinitis Pigmentosa (Retinitis) Market report?

Ans: The Applications covered in the Retinitis Pigmentosa (Retinitis) Market report are Hospitals, Eye Clinics, Other

What are the Type segmentation covered in the Retinitis Pigmentosa (Retinitis) Market report?

Ans: The Types covered in the Retinitis Pigmentosa (Retinitis) Market report are General Treatment, Traditional Chinese Medicine, Gene Therapy, The Surgical Treatment, Other

Recommended Reports

Retinal Diseases

Ophthalmic Drugs

Ophthalmic Devices

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinitis Pigmentosa (Retinitis) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 General Treatment
1.2.3 Traditional Chinese Medicine
1.2.4 Gene Therapy
1.2.5 The Surgical Treatment
1.2.6 Other
1.3 Market by Application
1.3.1 Global Retinitis Pigmentosa (Retinitis) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Eye Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Retinitis Pigmentosa (Retinitis) Market Perspective (2019-2030)
2.2 Global Retinitis Pigmentosa (Retinitis) Growth Trends by Region
2.2.1 Retinitis Pigmentosa (Retinitis) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Retinitis Pigmentosa (Retinitis) Historic Market Size by Region (2019-2024)
2.2.3 Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Region (2025-2030)
2.3 Retinitis Pigmentosa (Retinitis) Market Dynamics
2.3.1 Retinitis Pigmentosa (Retinitis) Industry Trends
2.3.2 Retinitis Pigmentosa (Retinitis) Market Drivers
2.3.3 Retinitis Pigmentosa (Retinitis) Market Challenges
2.3.4 Retinitis Pigmentosa (Retinitis) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Retinitis Pigmentosa (Retinitis) by Players
3.1.1 Global Retinitis Pigmentosa (Retinitis) Revenue by Players (2019-2024)
3.1.2 Global Retinitis Pigmentosa (Retinitis) Revenue Market Share by Players (2019-2024)
3.2 Global Retinitis Pigmentosa (Retinitis) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Retinitis Pigmentosa (Retinitis), Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Retinitis Pigmentosa (Retinitis) Market Concentration Ratio
3.4.1 Global Retinitis Pigmentosa (Retinitis) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinitis Pigmentosa (Retinitis) Revenue in 2023
3.5 Global Key Players of Retinitis Pigmentosa (Retinitis) Head office and Area Served
3.6 Global Key Players of Retinitis Pigmentosa (Retinitis), Product and Application
3.7 Global Key Players of Retinitis Pigmentosa (Retinitis), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Retinitis Pigmentosa (Retinitis) Breakdown Data by Type
4.1 Global Retinitis Pigmentosa (Retinitis) Historic Market Size by Type (2019-2024)
4.2 Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Type (2025-2030)
5 Retinitis Pigmentosa (Retinitis) Breakdown Data by Application
5.1 Global Retinitis Pigmentosa (Retinitis) Historic Market Size by Application (2019-2024)
5.2 Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Retinitis Pigmentosa (Retinitis) Market Size (2019-2030)
6.2 North America Retinitis Pigmentosa (Retinitis) Market Size by Type
6.2.1 North America Retinitis Pigmentosa (Retinitis) Market Size by Type (2019-2024)
6.2.2 North America Retinitis Pigmentosa (Retinitis) Market Size by Type (2025-2030)
6.2.3 North America Retinitis Pigmentosa (Retinitis) Market Share by Type (2019-2030)
6.3 North America Retinitis Pigmentosa (Retinitis) Market Size by Application
6.3.1 North America Retinitis Pigmentosa (Retinitis) Market Size by Application (2019-2024)
6.3.2 North America Retinitis Pigmentosa (Retinitis) Market Size by Application (2025-2030)
6.3.3 North America Retinitis Pigmentosa (Retinitis) Market Share by Application (2019-2030)
6.4 North America Retinitis Pigmentosa (Retinitis) Market Size by Country
6.4.1 North America Retinitis Pigmentosa (Retinitis) Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Retinitis Pigmentosa (Retinitis) Market Size by Country (2019-2024)
6.4.3 North America Retinitis Pigmentosa (Retinitis) Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Retinitis Pigmentosa (Retinitis) Market Size (2019-2030)
7.2 Europe Retinitis Pigmentosa (Retinitis) Market Size by Type
7.2.1 Europe Retinitis Pigmentosa (Retinitis) Market Size by Type (2019-2024)
7.2.2 Europe Retinitis Pigmentosa (Retinitis) Market Size by Type (2025-2030)
7.2.3 Europe Retinitis Pigmentosa (Retinitis) Market Share by Type (2019-2030)
7.3 Europe Retinitis Pigmentosa (Retinitis) Market Size by Application
7.3.1 Europe Retinitis Pigmentosa (Retinitis) Market Size by Application (2019-2024)
7.3.2 Europe Retinitis Pigmentosa (Retinitis) Market Size by Application (2025-2030)
7.3.3 Europe Retinitis Pigmentosa (Retinitis) Market Share by Application (2019-2030)
7.4 Europe Retinitis Pigmentosa (Retinitis) Market Size by Country
7.4.1 Europe Retinitis Pigmentosa (Retinitis) Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Retinitis Pigmentosa (Retinitis) Market Size by Country (2019-2024)
7.4.3 Europe Retinitis Pigmentosa (Retinitis) Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Retinitis Pigmentosa (Retinitis) Market Size (2019-2030)
8.2 China Retinitis Pigmentosa (Retinitis) Market Size by Type
8.2.1 China Retinitis Pigmentosa (Retinitis) Market Size by Type (2019-2024)
8.2.2 China Retinitis Pigmentosa (Retinitis) Market Size by Type (2025-2030)
8.2.3 China Retinitis Pigmentosa (Retinitis) Market Share by Type (2019-2030)
8.3 China Retinitis Pigmentosa (Retinitis) Market Size by Application
8.3.1 China Retinitis Pigmentosa (Retinitis) Market Size by Application (2019-2024)
8.3.2 China Retinitis Pigmentosa (Retinitis) Market Size by Application (2025-2030)
8.3.3 China Retinitis Pigmentosa (Retinitis) Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Retinitis Pigmentosa (Retinitis) Market Size (2019-2030)
9.2 Asia Retinitis Pigmentosa (Retinitis) Market Size by Type
9.2.1 Asia Retinitis Pigmentosa (Retinitis) Market Size by Type (2019-2024)
9.2.2 Asia Retinitis Pigmentosa (Retinitis) Market Size by Type (2025-2030)
9.2.3 Asia Retinitis Pigmentosa (Retinitis) Market Share by Type (2019-2030)
9.3 Asia Retinitis Pigmentosa (Retinitis) Market Size by Application
9.3.1 Asia Retinitis Pigmentosa (Retinitis) Market Size by Application (2019-2024)
9.3.2 Asia Retinitis Pigmentosa (Retinitis) Market Size by Application (2025-2030)
9.3.3 Asia Retinitis Pigmentosa (Retinitis) Market Share by Application (2019-2030)
9.4 Asia Retinitis Pigmentosa (Retinitis) Market Size by Region
9.4.1 Asia Retinitis Pigmentosa (Retinitis) Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Retinitis Pigmentosa (Retinitis) Market Size by Region (2019-2024)
9.4.3 Asia Retinitis Pigmentosa (Retinitis) Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Retinitis Pigmentosa (Retinitis) Introduction
11.1.4 Sanofi Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.1.5 Sanofi Recent Developments
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Retinitis Pigmentosa (Retinitis) Introduction
11.2.4 Amgen Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.2.5 Amgen Recent Developments
11.3 Amarantus Bioscience Holdings
11.3.1 Amarantus Bioscience Holdings Company Details
11.3.2 Amarantus Bioscience Holdings Business Overview
11.3.3 Amarantus Bioscience Holdings Retinitis Pigmentosa (Retinitis) Introduction
11.3.4 Amarantus Bioscience Holdings Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.3.5 Amarantus Bioscience Holdings Recent Developments
11.4 Acucela
11.4.1 Acucela Company Details
11.4.2 Acucela Business Overview
11.4.3 Acucela Retinitis Pigmentosa (Retinitis) Introduction
11.4.4 Acucela Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.4.5 Acucela Recent Developments
11.5 Applied Genetic Technologies Corp
11.5.1 Applied Genetic Technologies Corp Company Details
11.5.2 Applied Genetic Technologies Corp Business Overview
11.5.3 Applied Genetic Technologies Corp Retinitis Pigmentosa (Retinitis) Introduction
11.5.4 Applied Genetic Technologies Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.5.5 Applied Genetic Technologies Corp Recent Developments
11.6 Asklepios BioPharmaceutical
11.6.1 Asklepios BioPharmaceutical Company Details
11.6.2 Asklepios BioPharmaceutical Business Overview
11.6.3 Asklepios BioPharmaceutical Retinitis Pigmentosa (Retinitis) Introduction
11.6.4 Asklepios BioPharmaceutical Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.6.5 Asklepios BioPharmaceutical Recent Developments
11.7 Astellas Pharma
11.7.1 Astellas Pharma Company Details
11.7.2 Astellas Pharma Business Overview
11.7.3 Astellas Pharma Retinitis Pigmentosa (Retinitis) Introduction
11.7.4 Astellas Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.7.5 Astellas Pharma Recent Developments
11.8 Caladrius Biosciences
11.8.1 Caladrius Biosciences Company Details
11.8.2 Caladrius Biosciences Business Overview
11.8.3 Caladrius Biosciences Retinitis Pigmentosa (Retinitis) Introduction
11.8.4 Caladrius Biosciences Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.8.5 Caladrius Biosciences Recent Developments
11.9 Dompe Farmaceutici SpA
11.9.1 Dompe Farmaceutici SpA Company Details
11.9.2 Dompe Farmaceutici SpA Business Overview
11.9.3 Dompe Farmaceutici SpA Retinitis Pigmentosa (Retinitis) Introduction
11.9.4 Dompe Farmaceutici SpA Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.9.5 Dompe Farmaceutici SpA Recent Developments
11.10 Dormant Projects
11.10.1 Dormant Projects Company Details
11.10.2 Dormant Projects Business Overview
11.10.3 Dormant Projects Retinitis Pigmentosa (Retinitis) Introduction
11.10.4 Dormant Projects Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.10.5 Dormant Projects Recent Developments
11.11 GenSight Biologics SA
11.11.1 GenSight Biologics SA Company Details
11.11.2 GenSight Biologics SA Business Overview
11.11.3 GenSight Biologics SA Retinitis Pigmentosa (Retinitis) Introduction
11.11.4 GenSight Biologics SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.11.5 GenSight Biologics SA Recent Developments
11.12 Grupo Ferrer Internacional SA
11.12.1 Grupo Ferrer Internacional SA Company Details
11.12.2 Grupo Ferrer Internacional SA Business Overview
11.12.3 Grupo Ferrer Internacional SA Retinitis Pigmentosa (Retinitis) Introduction
11.12.4 Grupo Ferrer Internacional SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.12.5 Grupo Ferrer Internacional SA Recent Developments
11.13 ID Pharma
11.13.1 ID Pharma Company Details
11.13.2 ID Pharma Business Overview
11.13.3 ID Pharma Retinitis Pigmentosa (Retinitis) Introduction
11.13.4 ID Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.13.5 ID Pharma Recent Developments
11.14 InFlectis BioScience
11.14.1 InFlectis BioScience Company Details
11.14.2 InFlectis BioScience Business Overview
11.14.3 InFlectis BioScience Retinitis Pigmentosa (Retinitis) Introduction
11.14.4 InFlectis BioScience Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.14.5 InFlectis BioScience Recent Developments
11.15 Ionis Pharmaceuticals
11.15.1 Ionis Pharmaceuticals Company Details
11.15.2 Ionis Pharmaceuticals Business Overview
11.15.3 Ionis Pharmaceuticals Retinitis Pigmentosa (Retinitis) Introduction
11.15.4 Ionis Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.15.5 Ionis Pharmaceuticals Recent Developments
11.16 Mimetogen Pharmaceuticals
11.16.1 Mimetogen Pharmaceuticals Company Details
11.16.2 Mimetogen Pharmaceuticals Business Overview
11.16.3 Mimetogen Pharmaceuticals Retinitis Pigmentosa (Retinitis) Introduction
11.16.4 Mimetogen Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.16.5 Mimetogen Pharmaceuticals Recent Developments
11.17 M's Science Corp
11.17.1 M's Science Corp Company Details
11.17.2 M's Science Corp Business Overview
11.17.3 M's Science Corp Retinitis Pigmentosa (Retinitis) Introduction
11.17.4 M's Science Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.17.5 M's Science Corp Recent Developments
11.18 Nanovector srl
11.18.1 Nanovector srl Company Details
11.18.2 Nanovector srl Business Overview
11.18.3 Nanovector srl Retinitis Pigmentosa (Retinitis) Introduction
11.18.4 Nanovector srl Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.18.5 Nanovector srl Recent Developments
11.19 Novartis AG
11.19.1 Novartis AG Company Details
11.19.2 Novartis AG Business Overview
11.19.3 Novartis AG Retinitis Pigmentosa (Retinitis) Introduction
11.19.4 Novartis AG Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.19.5 Novartis AG Recent Developments
11.20 Novelion Therapeutics
11.20.1 Novelion Therapeutics Company Details
11.20.2 Novelion Therapeutics Business Overview
11.20.3 Novelion Therapeutics Retinitis Pigmentosa (Retinitis) Introduction
11.20.4 Novelion Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.20.5 Novelion Therapeutics Recent Developments
11.21 ProQR Therapeutics
11.21.1 ProQR Therapeutics Company Details
11.21.2 ProQR Therapeutics Business Overview
11.21.3 ProQR Therapeutics Retinitis Pigmentosa (Retinitis) Introduction
11.21.4 ProQR Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.21.5 ProQR Therapeutics Recent Developments
11.22 ReNeuron Group Plc
11.22.1 ReNeuron Group Plc Company Details
11.22.2 ReNeuron Group Plc Business Overview
11.22.3 ReNeuron Group Plc Retinitis Pigmentosa (Retinitis) Introduction
11.22.4 ReNeuron Group Plc Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.22.5 ReNeuron Group Plc Recent Developments
11.23 SanBio
11.23.1 SanBio Company Details
11.23.2 SanBio Business Overview
11.23.3 SanBio Retinitis Pigmentosa (Retinitis) Introduction
11.23.4 SanBio Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.23.5 SanBio Recent Developments
11.24 Shire (Takeda Pharmaceutical)
11.24.1 Shire (Takeda Pharmaceutical) Company Details
11.24.2 Shire (Takeda Pharmaceutical) Business Overview
11.24.3 Shire (Takeda Pharmaceutical) Retinitis Pigmentosa (Retinitis) Introduction
11.24.4 Shire (Takeda Pharmaceutical) Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.24.5 Shire (Takeda Pharmaceutical) Recent Developments
11.25 Spark Therapeutics
11.25.1 Spark Therapeutics Company Details
11.25.2 Spark Therapeutics Business Overview
11.25.3 Spark Therapeutics Retinitis Pigmentosa (Retinitis) Introduction
11.25.4 Spark Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.25.5 Spark Therapeutics Recent Developments
11.26 Sun Pharma Advanced Research Company
11.26.1 Sun Pharma Advanced Research Company Company Details
11.26.2 Sun Pharma Advanced Research Company Business Overview
11.26.3 Sun Pharma Advanced Research Company Retinitis Pigmentosa (Retinitis) Introduction
11.26.4 Sun Pharma Advanced Research Company Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
11.26.5 Sun Pharma Advanced Research Company Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Sanofi
Amgen Inc
Amarantus Bioscience Holdings
Acucela Inc
Applied Genetic Technologies Corp
Asklepios BioPharmaceutical
Astellas Pharma
Caladrius Biosciences
Dompe Farmaceutici SpA
Dormant Projects
GenSight Biologics SA
Grupo Ferrer Internacional SA
ID Pharma
InFlectis BioScience
Ionis Pharmaceuticals
Mimetogen Pharmaceuticals
M's Science Corp
Nanovector s.r.l.
Novartis
Novelion Therapeutics
ProQR Therapeutics
ReNeuron Group Plc
SanBio
Shire (Takeda Pharmaceutical)
Spark Therapeutics
Sun Pharma Advanced Research Company
List of Tables
    Table 1. Global Retinitis Pigmentosa (Retinitis) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of General Treatment
    Table 3. Key Players of Traditional Chinese Medicine
    Table 4. Key Players of Gene Therapy
    Table 5. Key Players of The Surgical Treatment
    Table 6. Key Players of Other
    Table 7. Global Retinitis Pigmentosa (Retinitis) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Retinitis Pigmentosa (Retinitis) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Retinitis Pigmentosa (Retinitis) Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Retinitis Pigmentosa (Retinitis) Market Share by Region (2019-2024)
    Table 11. Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Retinitis Pigmentosa (Retinitis) Market Share by Region (2025-2030)
    Table 13. Retinitis Pigmentosa (Retinitis) Market Trends
    Table 14. Retinitis Pigmentosa (Retinitis) Market Drivers
    Table 15. Retinitis Pigmentosa (Retinitis) Market Challenges
    Table 16. Retinitis Pigmentosa (Retinitis) Market Restraints
    Table 17. Global Retinitis Pigmentosa (Retinitis) Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Retinitis Pigmentosa (Retinitis) Revenue Share by Players (2019-2024)
    Table 19. Global Top Retinitis Pigmentosa (Retinitis) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinitis Pigmentosa (Retinitis) as of 2023)
    Table 20. Global Retinitis Pigmentosa (Retinitis) Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Retinitis Pigmentosa (Retinitis) Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Retinitis Pigmentosa (Retinitis), Headquarters and Area Served
    Table 23. Global Key Players of Retinitis Pigmentosa (Retinitis), Product and Application
    Table 24. Global Key Players of Retinitis Pigmentosa (Retinitis), Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Retinitis Pigmentosa (Retinitis) Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Retinitis Pigmentosa (Retinitis) Revenue Market Share by Type (2019-2024)
    Table 28. Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Retinitis Pigmentosa (Retinitis) Revenue Market Share by Type (2025-2030)
    Table 30. Global Retinitis Pigmentosa (Retinitis) Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Retinitis Pigmentosa (Retinitis) Revenue Share by Application (2019-2024)
    Table 32. Global Retinitis Pigmentosa (Retinitis) Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Retinitis Pigmentosa (Retinitis) Revenue Share by Application (2025-2030)
    Table 34. North America Retinitis Pigmentosa (Retinitis) Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Retinitis Pigmentosa (Retinitis) Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Retinitis Pigmentosa (Retinitis) Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Retinitis Pigmentosa (Retinitis) Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Retinitis Pigmentosa (Retinitis) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Retinitis Pigmentosa (Retinitis) Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Retinitis Pigmentosa (Retinitis) Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Retinitis Pigmentosa (Retinitis) Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Retinitis Pigmentosa (Retinitis) Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Retinitis Pigmentosa (Retinitis) Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Retinitis Pigmentosa (Retinitis) Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Retinitis Pigmentosa (Retinitis) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Retinitis Pigmentosa (Retinitis) Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Retinitis Pigmentosa (Retinitis) Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Retinitis Pigmentosa (Retinitis) Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Retinitis Pigmentosa (Retinitis) Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Retinitis Pigmentosa (Retinitis) Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Retinitis Pigmentosa (Retinitis) Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Retinitis Pigmentosa (Retinitis) Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Retinitis Pigmentosa (Retinitis) Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Retinitis Pigmentosa (Retinitis) Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Retinitis Pigmentosa (Retinitis) Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Retinitis Pigmentosa (Retinitis) Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Retinitis Pigmentosa (Retinitis) Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Retinitis Pigmentosa (Retinitis) Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Sanofi Company Details
    Table 67. Sanofi Business Overview
    Table 68. Sanofi Retinitis Pigmentosa (Retinitis) Product
    Table 69. Sanofi Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 70. Sanofi Recent Developments
    Table 71. Amgen Company Details
    Table 72. Amgen Business Overview
    Table 73. Amgen Retinitis Pigmentosa (Retinitis) Product
    Table 74. Amgen Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 75. Amgen Recent Developments
    Table 76. Amarantus Bioscience Holdings Company Details
    Table 77. Amarantus Bioscience Holdings Business Overview
    Table 78. Amarantus Bioscience Holdings Retinitis Pigmentosa (Retinitis) Product
    Table 79. Amarantus Bioscience Holdings Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 80. Amarantus Bioscience Holdings Recent Developments
    Table 81. Acucela Company Details
    Table 82. Acucela Business Overview
    Table 83. Acucela Retinitis Pigmentosa (Retinitis) Product
    Table 84. Acucela Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 85. Acucela Recent Developments
    Table 86. Applied Genetic Technologies Corp Company Details
    Table 87. Applied Genetic Technologies Corp Business Overview
    Table 88. Applied Genetic Technologies Corp Retinitis Pigmentosa (Retinitis) Product
    Table 89. Applied Genetic Technologies Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 90. Applied Genetic Technologies Corp Recent Developments
    Table 91. Asklepios BioPharmaceutical Company Details
    Table 92. Asklepios BioPharmaceutical Business Overview
    Table 93. Asklepios BioPharmaceutical Retinitis Pigmentosa (Retinitis) Product
    Table 94. Asklepios BioPharmaceutical Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 95. Asklepios BioPharmaceutical Recent Developments
    Table 96. Astellas Pharma Company Details
    Table 97. Astellas Pharma Business Overview
    Table 98. Astellas Pharma Retinitis Pigmentosa (Retinitis) Product
    Table 99. Astellas Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 100. Astellas Pharma Recent Developments
    Table 101. Caladrius Biosciences Company Details
    Table 102. Caladrius Biosciences Business Overview
    Table 103. Caladrius Biosciences Retinitis Pigmentosa (Retinitis) Product
    Table 104. Caladrius Biosciences Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 105. Caladrius Biosciences Recent Developments
    Table 106. Dompe Farmaceutici SpA Company Details
    Table 107. Dompe Farmaceutici SpA Business Overview
    Table 108. Dompe Farmaceutici SpA Retinitis Pigmentosa (Retinitis) Product
    Table 109. Dompe Farmaceutici SpA Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 110. Dompe Farmaceutici SpA Recent Developments
    Table 111. Dormant Projects Company Details
    Table 112. Dormant Projects Business Overview
    Table 113. Dormant Projects Retinitis Pigmentosa (Retinitis) Product
    Table 114. Dormant Projects Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 115. Dormant Projects Recent Developments
    Table 116. GenSight Biologics SA Company Details
    Table 117. GenSight Biologics SA Business Overview
    Table 118. GenSight Biologics SA Retinitis Pigmentosa (Retinitis) Product
    Table 119. GenSight Biologics SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 120. GenSight Biologics SA Recent Developments
    Table 121. Grupo Ferrer Internacional SA Company Details
    Table 122. Grupo Ferrer Internacional SA Business Overview
    Table 123. Grupo Ferrer Internacional SA Retinitis Pigmentosa (Retinitis) Product
    Table 124. Grupo Ferrer Internacional SA Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 125. Grupo Ferrer Internacional SA Recent Developments
    Table 126. ID Pharma Company Details
    Table 127. ID Pharma Business Overview
    Table 128. ID Pharma Retinitis Pigmentosa (Retinitis) Product
    Table 129. ID Pharma Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 130. ID Pharma Recent Developments
    Table 131. InFlectis BioScience Company Details
    Table 132. InFlectis BioScience Business Overview
    Table 133. InFlectis BioScience Retinitis Pigmentosa (Retinitis) Product
    Table 134. InFlectis BioScience Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 135. InFlectis BioScience Recent Developments
    Table 136. Ionis Pharmaceuticals Company Details
    Table 137. Ionis Pharmaceuticals Business Overview
    Table 138. Ionis Pharmaceuticals Retinitis Pigmentosa (Retinitis) Product
    Table 139. Ionis Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 140. Ionis Pharmaceuticals Recent Developments
    Table 141. Mimetogen Pharmaceuticals Company Details
    Table 142. Mimetogen Pharmaceuticals Business Overview
    Table 143. Mimetogen Pharmaceuticals Retinitis Pigmentosa (Retinitis) Product
    Table 144. Mimetogen Pharmaceuticals Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 145. Mimetogen Pharmaceuticals Recent Developments
    Table 146. M's Science Corp Company Details
    Table 147. M's Science Corp Business Overview
    Table 148. M's Science Corp Retinitis Pigmentosa (Retinitis) Product
    Table 149. M's Science Corp Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 150. M's Science Corp Recent Developments
    Table 151. Nanovector srl Company Details
    Table 152. Nanovector srl Business Overview
    Table 153. Nanovector srl Retinitis Pigmentosa (Retinitis) Product
    Table 154. Nanovector srl Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 155. Nanovector srl Recent Developments
    Table 156. Novartis AG Company Details
    Table 157. Novartis AG Business Overview
    Table 158. Novartis AG Retinitis Pigmentosa (Retinitis) Product
    Table 159. Novartis AG Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 160. Novartis AG Recent Developments
    Table 161. Novelion Therapeutics Company Details
    Table 162. Novelion Therapeutics Business Overview
    Table 163. Novelion Therapeutics Retinitis Pigmentosa (Retinitis) Product
    Table 164. Novelion Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 165. Novelion Therapeutics Recent Developments
    Table 166. ProQR Therapeutics Company Details
    Table 167. ProQR Therapeutics Business Overview
    Table 168. ProQR Therapeutics Retinitis Pigmentosa (Retinitis) Product
    Table 169. ProQR Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 170. ProQR Therapeutics Recent Developments
    Table 171. ReNeuron Group Plc Company Details
    Table 172. ReNeuron Group Plc Business Overview
    Table 173. ReNeuron Group Plc Retinitis Pigmentosa (Retinitis) Product
    Table 174. ReNeuron Group Plc Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 175. ReNeuron Group Plc Recent Developments
    Table 176. SanBio Company Details
    Table 177. SanBio Business Overview
    Table 178. SanBio Retinitis Pigmentosa (Retinitis) Product
    Table 179. SanBio Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 180. SanBio Recent Developments
    Table 181. Shire (Takeda Pharmaceutical) Company Details
    Table 182. Shire (Takeda Pharmaceutical) Business Overview
    Table 183. Shire (Takeda Pharmaceutical) Retinitis Pigmentosa (Retinitis) Product
    Table 184. Shire (Takeda Pharmaceutical) Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 185. Shire (Takeda Pharmaceutical) Recent Developments
    Table 186. Spark Therapeutics Company Details
    Table 187. Spark Therapeutics Business Overview
    Table 188. Spark Therapeutics Retinitis Pigmentosa (Retinitis) Product
    Table 189. Spark Therapeutics Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 190. Spark Therapeutics Recent Developments
    Table 191. Sun Pharma Advanced Research Company Company Details
    Table 192. Sun Pharma Advanced Research Company Business Overview
    Table 193. Sun Pharma Advanced Research Company Retinitis Pigmentosa (Retinitis) Product
    Table 194. Sun Pharma Advanced Research Company Revenue in Retinitis Pigmentosa (Retinitis) Business (2019-2024) & (US$ Million)
    Table 195. Sun Pharma Advanced Research Company Recent Developments
    Table 196. Research Programs/Design for This Report
    Table 197. Key Data Information from Secondary Sources
    Table 198. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Retinitis Pigmentosa (Retinitis) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Retinitis Pigmentosa (Retinitis) Market Share by Type: 2023 VS 2030
    Figure 3. General Treatment Features
    Figure 4. Traditional Chinese Medicine Features
    Figure 5. Gene Therapy Features
    Figure 6. The Surgical Treatment Features
    Figure 7. Other Features
    Figure 8. Global Retinitis Pigmentosa (Retinitis) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Retinitis Pigmentosa (Retinitis) Market Share by Application: 2023 VS 2030
    Figure 10. Hospitals Case Studies
    Figure 11. Eye Clinics Case Studies
    Figure 12. Other Case Studies
    Figure 13. Retinitis Pigmentosa (Retinitis) Report Years Considered
    Figure 14. Global Retinitis Pigmentosa (Retinitis) Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Retinitis Pigmentosa (Retinitis) Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Retinitis Pigmentosa (Retinitis) Market Share by Region: 2023 VS 2030
    Figure 17. Global Retinitis Pigmentosa (Retinitis) Market Share by Players in 2023
    Figure 18. Global Top Retinitis Pigmentosa (Retinitis) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinitis Pigmentosa (Retinitis) as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Retinitis Pigmentosa (Retinitis) Revenue in 2023
    Figure 20. North America Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Retinitis Pigmentosa (Retinitis) Market Share by Type (2019-2030)
    Figure 22. North America Retinitis Pigmentosa (Retinitis) Market Share by Application (2019-2030)
    Figure 23. North America Retinitis Pigmentosa (Retinitis) Market Share by Country (2019-2030)
    Figure 24. United States Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Retinitis Pigmentosa (Retinitis) Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Retinitis Pigmentosa (Retinitis) Market Share by Type (2019-2030)
    Figure 28. Europe Retinitis Pigmentosa (Retinitis) Market Share by Application (2019-2030)
    Figure 29. Europe Retinitis Pigmentosa (Retinitis) Market Share by Country (2019-2030)
    Figure 30. Germany Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Retinitis Pigmentosa (Retinitis) Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Retinitis Pigmentosa (Retinitis) Market Share by Type (2019-2030)
    Figure 38. China Retinitis Pigmentosa (Retinitis) Market Share by Application (2019-2030)
    Figure 39. Asia Retinitis Pigmentosa (Retinitis) Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Retinitis Pigmentosa (Retinitis) Market Share by Type (2019-2030)
    Figure 41. Asia Retinitis Pigmentosa (Retinitis) Market Share by Application (2019-2030)
    Figure 42. Asia Retinitis Pigmentosa (Retinitis) Market Share by Region (2019-2030)
    Figure 43. Japan Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Retinitis Pigmentosa (Retinitis) Market Share by Country (2019-2030)
    Figure 53. Brazil Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Retinitis Pigmentosa (Retinitis) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Sanofi Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 60. Amgen Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 61. Amarantus Bioscience Holdings Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 62. Acucela Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 63. Applied Genetic Technologies Corp Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 64. Asklepios BioPharmaceutical Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 65. Astellas Pharma Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 66. Caladrius Biosciences Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 67. Dompe Farmaceutici SpA Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 68. Dormant Projects Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 69. GenSight Biologics SA Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 70. Grupo Ferrer Internacional SA Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 71. ID Pharma Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 72. InFlectis BioScience Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 73. Ionis Pharmaceuticals Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 74. Mimetogen Pharmaceuticals Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 75. M's Science Corp Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 76. Nanovector srl Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 77. Novartis AG Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 78. Novelion Therapeutics Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 79. ProQR Therapeutics Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 80. ReNeuron Group Plc Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 81. SanBio Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 82. Shire (Takeda Pharmaceutical) Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 83. Spark Therapeutics Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 84. Sun Pharma Advanced Research Company Revenue Growth Rate in Retinitis Pigmentosa (Retinitis) Business (2019-2024)
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Ophthalmology Disorders Drug Market Insights Forecast to 2030
Global Retinitis Pigmentosa Treatment Market Research Report 2024
Global Age Related Macular Degeneration AMD Therapeutics Market Insights Forecast to 2030
Global Age Related Macular Degeneration Treatment Market Insights Forecast to 2030
Global Macular Degeneration AMD and Other Retinal Diseases Market Research Report 2024
Global Age Related Macular Degeneration Drug Market Insights Forecast to 2030
Global Retinal Disorders Treatment Market Research Report 2024
Choroideremia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cytomegalovirus Retinitis Treatment Market Research Report 2024
Global Ophthalmology for Age related Macular Degeneration Diseases Market Research Report 2024
Global Cone rod Dystrophy Treatment Market Research Report 2025
Global Albinism Drug Market Insights Forecast to 2030
Global Macular Edema and Macular Degeneration Market Research Report 2025
Retinal Dystrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Geographic Atrophy Market Research Report 2025
Global Neurodegenerative Disease Market Insights Forecast to 2030
Retinal Prosthesis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vitiligo Therapeutics Market Research Report 2024
Global Retinal Disease Therapeutics Market Research Report 2024
Retinal Degenerative Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions